Rationale and First Results of Developing At-Risk (Prodromal) Criteria for Bipolar Disorder

Publisher： Bentham Science Publishers

E-ISSN： 1873-4286|18|4|358-375

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.18, Iss.4, 2012-02, pp. : 358-375

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Protein Kinase C Inhibitors: Rationale for Use and Potential in the Treatment of Bipolar Disorder

By Zarate Carlos A.   Manji Husseini K.  

CNS Drugs, Vol. 23, Iss. 7, 2009-07 ,pp. : 569-582

Adis International

Access to resources Recommend Favorite

Newer Antiepileptic Drugs in Bipolar Disorder: Rationale for Use and Role in Therapy

By Macdonald K.J.   Young L.T.  

CNS Drugs, Vol. 16, Iss. 8, 2002-01 ,pp. : 549-562

Adis International

Access to resources Recommend Favorite

Sildenafil: First report of bipolar disorder: case report

By  

Reactions Weekly, Vol. 1, Iss. 1055, 2005-01 ,pp. : 14-15

Adis International

Access to resources Recommend Favorite

Suicidal Behaviour in Bipolar Disorder: Risk and Prevention

By Tondo L.   Isacsson G.  

CNS Drugs, Vol. 17, Iss. 7, 2003-01 ,pp. : 491-511

Adis International

Access to resources Recommend Favorite

Lithium is still a first-line option in the treatment of patients with bipolar disorder

By  

Drugs & Therapy Perspectives, Vol. 26, Iss. 3, 2010-03 ,pp. : 9-14

Adis International

Access to resources Recommend Favorite